Preclinical activity of hepsulfam and busulfan in solid human tumor xenografts and human bone marrow.

In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrow.

Tissue penetration and activity of camptothecins in solid tumor xenografts.

Survival of free and encapsulated human and rat islet xenografts transplanted into the mouse bone marrow.

A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts.

Metastatic growth of human tumour xenografts in thymectomised irradiated micr reconstituted with syngeneic bone marrow cells.

Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma.

Human bone marrow transplantation.

Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells.

Establishment and characterization of five new human renal tumor xenografts.

$Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue.$
Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue.

Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.

Activity of human carcinogens in the Salmonella and rodent bone marrow cytogenetic tests.

Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts.

Polyploid mitoses in human bone-marrow cells.

Thymus-dependent lymphocytes in human bone marrow.

Formation and proliferative effects of lipoxins in human bone marrow.

Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests.

The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts.

Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.

Preclinical phase II study of ifosfamide in human tumour xenografts in vivo.

Genetic activity of the human carcinogen sulphur mustard towards Salmonella and the mouse bone marrow.

Autologous bone marrow transplantation in solid tumors.

Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.

Pneumococcal infections after human bone-marrow transplantation.

Suggest Documents

In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrow.

Tissue penetration and activity of camptothecins in solid tumor xenografts.

Survival of free and encapsulated human and rat islet xenografts transplanted into the mouse bone marrow.

A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts.

Metastatic growth of human tumour xenografts in thymectomised irradiated micr reconstituted with syngeneic bone marrow cells.

Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma.

Human bone marrow transplantation.

Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells.

Establishment and characterization of five new human renal tumor xenografts.

Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue.

Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.

Activity of human carcinogens in the Salmonella and rodent bone marrow cytogenetic tests.

Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts.

Polyploid mitoses in human bone-marrow cells.

Thymus-dependent lymphocytes in human bone marrow.

Formation and proliferative effects of lipoxins in human bone marrow.

Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests.

The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts.

Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.

Preclinical phase II study of ifosfamide in human tumour xenografts in vivo.

Genetic activity of the human carcinogen sulphur mustard towards Salmonella and the mouse bone marrow.

Autologous bone marrow transplantation in solid tumors.

Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.

Pneumococcal infections after human bone-marrow transplantation.

Preclinical activity of hepsulfam and busulfan in solid human tumor xenografts and human bone marrow.

Recommend Documents

Follow Us